JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Millan, M. J.
Right arrow Articles by Herz, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Millan, M. J.
Right arrow Articles by Herz, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MORPHINE
*NALOXONE

Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists

MJ Millan, BJ Morris and A Herz

Department of Neuropharmacology, Max-Planck-Institut fur Psychiatrie, Planegg-Martinsried, Federal Republic of Germany.

In this study, chronic opioid antagonist-induced alterations in sensitivity to selective mu- and kappa-opioid agonists were examined. Administration of naloxone (0.5 mg/kg/hr) via osmotic minipumps eliminated the antinociception elicited by the mu-agonist, morphine, but did not affect that induced by the kappa-agonist, U50, 488H. After 1 week of treatment and after pump removal, dose-response curves for the induction of antinociception by morphine against noxious heat, pressure and electrical stimulation were shifted to the left across the entire time course of action: this supersensitivity subsided over a period of 1 week postremoval. No facilitation of the actions of U50,488H was seen. Three days of infusion also induced a significant supersensitivity to morphine but a single, acute high dose of naloxone (3.0 mg/kg) was ineffective. The effect of naloxone was dose-dependent (0.05-0.50 mg/kg/hr). Chronic treatment at 3.0 mg/kg/hr blocked the antinociception induced by both U50,488H and morphine. After 1 week and after pump removal, the antinociceptive action of U50,488H against pressure, but not heat, was enhanced; the antinociceptive action of morphine against both heat and pressure was facilitated. These data, in conjunction with our autoradiographical findings suggest: 1) it is possible to selectively block and up-regulate mu as compared to kappa receptors; 2) chronic treatment with naloxone can induce a supersensitivity to kappa-agonists; and 3) the pool of kappa-receptors acting antinociceptively against pressure may differ from that acting against heat.

Volume 247, Issue 2, pp. 721-728, 11/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Chen, C. Chen, Y. Wang, and L.-Y. Liu-Chen
Ligands Regulate Cell Surface Level of the Human {kappa} Opioid Receptor by Activation-Induced Down-Regulation and Pharmacological Chaperone-Mediated Enhancement: Differential Effects of Nonpeptide and Peptide Agonists
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 765 - 775.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
I. Okulicz-Kozaryn, P. Mikolajczak, E. Kaminska, I. Kaminska, M. Szulc, and T. Bobkiewicz-Kozlowska
EFFECT OF NALTREXONE ADMINISTRATION ON SHORT-TERM MEMORY IN CHRONICALLY ETHANOL-TREATED OUTBRED RATS
Alcohol Alcohol., January 1, 2004; 39(1): 14 - 19.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics.